M&A Analysis: Big Medtechs Relentless On Acquisition Path As July Activity Heats Up
Medtech M&A activity heated up in July with 19 acquisitions announced and closed during the month, an increase in activity compared to the 12 deals recorded in June but didn’t match the 25 acquisitions recorded in July 2017.
You may also be interested in...
Boston Scientific has inked a deal of up to $270m for embolic protection system developer Claret Medical, marking its second acquisition in the space of two weeks.
With Johnson & Johnson bowing out of the diabetes device market, US firm CeQur has benefited from by securing assets from the health-care giant's Calibra Medical insulin delivery device business.
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.